Brii Biosciences Limited (HKG:2137)
Hong Kong · Delayed Price · Currency is HKD 1.560
+0.070 (4.70%)
Feb 13, 2026, 4:08 PM HKT
Brii Biosciences Market Cap
Brii Biosciences has a market cap or net worth of 1.13 billion as of February 13, 2026. Its market cap has increased by 37.01% in one year.
Market Cap
1.13B
Enterprise Value
-1.20B
Revenue
31.53M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.56
Market Cap Chart
Since July 13, 2021, Brii Biosciences's market cap has decreased from 16.21B to 1.13B, a decrease of -93.06%. That is a compound annual growth rate of -44.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 1.13B | 10.69% |
| Dec 31, 2025 | 1.02B | 41.89% |
| Dec 31, 2024 | 716.67M | -56.90% |
| Dec 29, 2023 | 1.66B | -68.96% |
| Dec 30, 2022 | 5.36B | -77.39% |
| Dec 31, 2021 | 23.70B | 46.22% |
| Jul 13, 2021 | 16.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immunotech Biopharm | 1.56B |
| HighTide Therapeutics | 1.50B |
| Shanghai Bio-heart Biological Technology | 1.46B |
| Wuhan YZY Biopharma | 1.40B |
| Kintor Pharmaceutical | 1.33B |
| Beijing Biostar Pharmaceuticals | 1.30B |
| 3D Medicines | 1.10B |
| Transcenta Holding | 1.10B |